Update in asthma 2009.
Moore
Wendy C
WC
Center for Genomics and Personalized Medicine and Section on Pulmonary, Critical Care, Allergy and Immunologic Diseases, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA. wmoore@wfubmc.edu
Pascual
Rodolfo M
RM
D000445:Aldehyde Oxidoreductases / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001249:Asthma / Q000150:complications / Q000188:drug therapy* / Q000235:genetics* / Q000276:immunology; D002986:Clinical Trials as Topic; D004196:Disease Outbreaks; D004198:Disease Susceptibility; D005764:Gastroesophageal Reflux / Q000150:complications / Q000188:drug therapy; D006801:Humans; D056747:Immunomodulation; D053118:Influenza A Virus, H1N1 Subtype; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000453:epidemiology; D015848:Interleukin-5 / Q000037:antagonists & inhibitors; D017410:Practice Guidelines as Topic; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D018418:Th2 Cells / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014807:Vitamin D / Q000097:blood
D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D007252:Influenza Vaccines; D015848:Interleukin-5; D054328:Proton Pump Inhibitors; D014409:Tumor Necrosis Factor-alpha; D014807:Vitamin D; D000445:Aldehyde Oxidoreductases; C087006:formaldehyde dehydrogenase, glutathione-independent